MedTrace Logo

Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting

NCT03049085 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2017-02-09

No results posted yet for this study

Summary

Effect of Preoperative Aspirin in patients undergoing Off-pump Coronary Artery Bypass Grafting. A double-blind, placebo-controlled, randomized trial.

Conditions

Interventions

DRUG

Aspirin

preoperative uncoated 75 mg Aspirin is administered 2 hours prior OPCAB

DRUG

vitamin C

preoperative 75 mg Vit. C (Placebo) is administered 2 hours prior OPCAB

Sponsors & Collaborators

  • Medinet Heart Centre

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2018-05-31
Completion
2019-05-31
FDA Drug
Yes

Countries

  • Poland

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03049085 on ClinicalTrials.gov